Clinical Trial on Agitation in Alzheimer's Dementia

Clinical trial NCT05543681 · RECRUITING

Trial details

NCT number: NCT05543681
Sponsor: IGC Pharma, LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Agitation,Psychomotor Care Giving Burden NPS Aggression

Start date: 2022-10-11
Primary completion: 2026-08-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.